Verve Therapeutics Statistics
Total Valuation
CWK has a market cap or net worth of $3.14 billion. The enterprise value is $5.72 billion.
| Market Cap | 3.14B |
| Enterprise Value | 5.72B |
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CWK has 231.47 million shares outstanding. The number of shares has increased by 3.05% in one year.
| Current Share Class | 231.47M |
| Shares Outstanding | 231.47M |
| Shares Change (YoY) | +3.05% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 1.22% |
| Owned by Institutions (%) | 98.59% |
| Float | 228.60M |
Valuation Ratios
The trailing PE ratio is 15.54 and the forward PE ratio is 10.73.
| PE Ratio | 15.54 |
| Forward PE | 10.73 |
| PS Ratio | 0.32 |
| Forward PS | 0.30 |
| PB Ratio | 1.63 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.54 |
| P/OCF Ratio | 19.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.17, with an EV/FCF ratio of 45.31.
| EV / Earnings | 27.81 |
| EV / Sales | 0.59 |
| EV / EBITDA | 10.17 |
| EV / EBIT | 12.68 |
| EV / FCF | 45.31 |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.70.
| Current Ratio | 1.13 |
| Quick Ratio | 1.04 |
| Debt / Equity | 1.70 |
| Debt / EBITDA | 4.61 |
| Debt / FCF | 25.67 |
| Interest Coverage | 2.13 |
Financial Efficiency
Return on equity (ROE) is 11.62% and return on invested capital (ROIC) is 5.53%.
| Return on Equity (ROE) | 11.62% |
| Return on Assets (ROA) | 3.79% |
| Return on Invested Capital (ROIC) | 5.53% |
| Return on Capital Employed (ROCE) | 8.63% |
| Revenue Per Employee | $187,350 |
| Profits Per Employee | $3,958 |
| Employee Count | 52,000 |
| Asset Turnover | 1.31 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CWK has paid $60.50 million in taxes.
| Income Tax | 60.50M |
| Effective Tax Rate | 22.72% |
Stock Price Statistics
The stock price has increased by +12.42% in the last 52 weeks. The beta is 1.51, so CWK's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | +12.42% |
| 50-Day Moving Average | 11.32 |
| 200-Day Moving Average | 11.90 |
| Relative Strength Index (RSI) | 71.09 |
| Average Volume (20 Days) | 2,345,727 |
Short Selling Information
The latest short interest is 10.62 million, so 4.59% of the outstanding shares have been sold short.
| Short Interest | 10.62M |
| Short Previous Month | 8.62M |
| Short % of Shares Out | 4.59% |
| Short % of Float | 4.65% |
| Short Ratio (days to cover) | 4.92 |
Income Statement
In the last 12 months, CWK had revenue of $9.74 billion and earned $205.80 million in profits. Earnings per share was $0.87.
| Revenue | 9.74B |
| Gross Profit | 1.81B |
| Operating Income | 451.50M |
| Pretax Income | 43.50M |
| Net Income | 205.80M |
| EBITDA | 562.90M |
| EBIT | 451.50M |
| Earnings Per Share (EPS) | $0.87 |
Balance Sheet
The company has $618.20 million in cash and $3.24 billion in debt, giving a net cash position of -$2.62 billion or -$11.33 per share.
| Cash & Cash Equivalents | 618.20M |
| Total Debt | 3.24B |
| Net Cash | -2.62B |
| Net Cash Per Share | -$11.33 |
| Equity (Book Value) | 1.90B |
| Book Value Per Share | 8.22 |
| Working Capital | 311.60M |
Cash Flow
In the last 12 months, operating cash flow was $158.90 million and capital expenditures -$32.60 million, giving a free cash flow of $126.30 million.
| Operating Cash Flow | 158.90M |
| Capital Expenditures | -32.60M |
| Free Cash Flow | 126.30M |
| FCF Per Share | $0.55 |
Margins
Gross margin is 18.60%, with operating and profit margins of 4.63% and 2.11%.
| Gross Margin | 18.60% |
| Operating Margin | 4.63% |
| Pretax Margin | 2.73% |
| Profit Margin | 2.11% |
| EBITDA Margin | 5.78% |
| EBIT Margin | 4.63% |
| FCF Margin | 1.30% |
Dividends & Yields
CWK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.05% |
| Shareholder Yield | -3.05% |
| Earnings Yield | 6.64% |
| FCF Yield | 4.07% |
Analyst Forecast
The average price target for CWK is $14.29, which is 5.19% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.29 |
| Price Target Difference | 5.19% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 5.28% |
| EPS Growth Forecast (5Y) | 27.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CWK has an Altman Z-Score of 1.66 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.66 |
| Piotroski F-Score | 6 |